KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Change in Cash (2016 - 2025)

Historic Change in Cash for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to -$2.6 billion.

  • Thermo Fisher Scientific's Change in Cash fell 679.85% to -$2.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.7 billion, marking a year-over-year decrease of 7750.33%. This contributed to the annual value of -$4.1 billion for FY2024, which is 82204.55% down from last year.
  • According to the latest figures from Q3 2025, Thermo Fisher Scientific's Change in Cash is -$2.6 billion, which was down 679.85% from $431.0 million recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Change in Cash registered a high of $5.6 billion during Q4 2022, and its lowest value of -$7.6 billion during Q4 2021.
  • Over the past 5 years, Thermo Fisher Scientific's median Change in Cash value was -$347.0 million (recorded in 2023), while the average stood at -$438.2 million.
  • Per our database at Business Quant, Thermo Fisher Scientific's Change in Cash crashed by 90493.2% in 2021 and then surged by 55475.5% in 2024.
  • Thermo Fisher Scientific's Change in Cash (Quarter) stood at -$7.6 billion in 2021, then soared by 174.14% to $5.6 billion in 2022, then crashed by 65.57% to $1.9 billion in 2023, then plummeted by 132.66% to -$630.0 million in 2024, then crashed by 311.43% to -$2.6 billion in 2025.
  • Its last three reported values are -$2.6 billion in Q3 2025, $431.0 million for Q2 2025, and $132.0 million during Q1 2025.